Scientific ReportsNeurosciencePeer-reviewed journal article
Toxicity of extracellular alpha-synuclein is independent of intracellular alpha-synuclein
Yanina Dening, Theresa Straßl, Viktoria RufiD, Petra Dirscherl, Alexandra Chovsepian, Aliçia StiévenardiD, Amit KhairnariD, Felix SchmidtiD, Florian GiesertiD, Jochen Wolfgang HermsiD, Johannes LeviniD, Marianne DieterichiD, Peter FalkaiiD, Daniela M. Vogt WeisenhorniD, Wolfgang WurstiD, Armin GieseiD, Francisco J. Pan-MontojoiD
- Citations
- 9
- FWCI
- 0.79
- Field percentile
- top 28%
Abstract
Parkinson's disease (PD) pathology progresses throughout the nervous system affecting numerous neuronal structures. It has been postulated that the progression of the pathology is based on a prion-like disease mechanism partly due to the seeding effect of endocytosed alpha-synuclein (ASYN) on the endogenous ASYN. The appearance of the pathology in dopaminergic neurons leads to neuronal cell death and motor symptoms. However, the effect on other neuronal structures is more inconsistent, leading to a higher variability in the prevalence of non-motor symptoms. Thus, the sensitivity to the pathology seems to vary among neuronal subtypes. Here, we analyzed the role of endogenous ASYN in the progression of PD-like pathology and the effect of monomeric and oligomeric ASYN as well as paraquat and rotenone on primary enteric, dopaminergic and cortical neurons from wild-type mice. Our results showed that pathology progression did not occur in the absence of endogenous ASYN and that dopaminergic neurons were more sensitive to ASYN and rotenone when compared to all other neuronal subtypes. Remarkably, the toxic effect of ASYN was independent of the presence of endogenous ASYN and directly related to the disturbance of the mitochondrial membrane potential. Thus, we suggest that the interaction between ASYN and mitochondria plays an important role in the toxicity of trans-synaptically transported ASYN and in the progression of PD pathology. These results question the prion-disease hypothesis and propose that endocytosed ASYN impairs the host's mitochondrial function thereby also contributing to PD-pathology progression.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Alpha-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinsons disease
Fanni F. Geibl, Martin T. Henrich, … Dalton James Surmeier·Molecular NeurodegenerationPeer-reviewed·Oct 8, 2024
- Exosomal transmission of α-synuclein initiates Parkinson's disease-like pathology
Jason A. Howitt, Ley Hian Low, … Seong‐Seng Tan·bioRxiv·May 10, 2021
- Alpha-synuclein and neuromelanin converge to promote Parkinsons disease pathology
Alba Nicolau, Marta González-Sepúlveda, … Miquel Vila·bioRxiv·Oct 24, 2026
- Pronounced α-synuclein pathology in a seeding-based mouse model is not sufficient to induce mitochondrial respiration deficits in the striatum and amygdala
Johannes Burtscher, Jean‐Christophe Copin, … Hilal Ahmed Lashuel·eNeuroPeer-reviewed·Jun 2, 2020
- Glucosylceramide induced ectosomes propagate pathogenic α-synuclein in Parkinson's disease
Julie Jacquemyn, Brian A. Marriott, … Maria S. Ioannou·Nature Cell BiologyPeer-reviewed·Feb 12, 2026
- Transgenic mice expressing human alpha-synuclein in noradrenergic neurons develop locus coeruleus pathology and non-motor features of Parkinson's disease
Laura M. Butkovich, Madelyn C. Houser, … Malú G. Tansey·Journal of NeurosciencePeer-reviewed·Aug 31, 2020